High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 6, 2009, Pages 987-993

  Doumbo, Ogobara K ^a   Thera, Mahamadou A ^a   Koné, Abdoulaye K ^a   Raza, Ahmed ^b   Tempest, Louisa J ^b   Lyke, Kirsten E ^c   Plowe, Christopher V ^c   Rowe, J Alexandra ^b  

^a UNIVERSITY OF BAMAKO   (Mali)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; COMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; JAUNDICE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALI; NONHUMAN; PARASITE ISOLATION; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; ROSETTE FORMATION; SEIZURE; AFRICA SOUTH OF THE SAHARA; ANIMAL; BLOOD; CASE CONTROL STUDY; INFANT; PATHOGENICITY; PHYSIOLOGY; PRESCHOOL CHILD; VIRULENCE;

MALIA; PLASMODIUM FALCIPARUM;

AFRICA SOUTH OF THE SAHARA; ANIMALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; ROSETTE FORMATION; VIRULENCE;

EID: 73949148720     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.09-0406     Document Type: Article

References (44)

1. Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M, 1990. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336: 1457-1460.
2. Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A,Twumasi P, Kwiatkowski D, Greenwood BM, Wahlgren M, 1992. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 46: 503-510.
3. Ringwald P, Peyron F, Lepers JP, Rabarison P, Rakotomalala C, Razanamparany M, Rabodonirina M, Roux J, Le Bras J, 1993. Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun 61: 5198-5204.
4. Rowe A, Obeiro J, Newbold CI, Marsh K, 1995. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323-2326.
5. Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, Msobo M, Peshu N, Marsh K, 1997. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 57: 389-398.
6. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, Matousek P, Kremsner PG, 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans R Soc Trop Med Hyg 92: 110-114.
7. Pain A, Ferguson DJ, Kai O, Urban BC, Lowe B, Marsh K, Roberts DJ, 2001. Platelet-mediated clumping of Plasmodium faltiparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci USA 98: 1805-1810.
8. Heddini A,Pettersson F,Kai O,Shafi J,Obiero J,Chen Q, Barragan A, Wahlgren M, Marsh K, 2001. Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 69: 5849-5856.
9. Rowe JA, Shafi J, Kai OK, Marsh K, Raza A, 2002. Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria. Am J Trop Med Hyg 66: 692-699.
10. Kaul DK, Roth EFJ, Nagel RL, Howard RJ, Handunnetti SM, 1991. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 78: 812-819.
11. Dondorp AM, Ince C, Charunwatthana P, Hanson J, van Kuijen A, Faiz MA, Rahman MR, Hasan M, Bin Yunus E, Ghose A, Ruangveerayut R, Limmathurotsakul D,Mathura K, White NJ, Day NP, 2008. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis 197: 79-84.
12. Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME, 2009. Perfusion abnormalities in children with cerebral malaria and malarial retinopathy.J Infect Dis 199: 263-271.
13. Rowe JA, Moulds JM, Newbold CI, Miller LH, 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292-295.
14. Carlson J, Nash GB, Gabutti V, al-Yaman F, Wahlgren M, 1994. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood 84: 3909-3914.
15. Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, Bockarie M, Reeder JC, Rowe JA, 2004. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci USA 101: 272-277.
16. Rowe JA, Handel IG.Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM, 2007. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci USA 104: 17471-17476.
17. Rowe JA, Claessens A, Corrigan RA, Arman M, 2009. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 11: e16.
18. Carlson J,Ekre HP, Helmby H,Gysin J,Greenwood BM,Wahlgren M, 1992. Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. Am J Trop Med Hyg 46: 595-602.
19. Rowe A, Berendt AR, Marsh K, Newbold CI, 1994. Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. Exp Parasitol 79: 506-516.
20. Vogt AM, Pettersson F, Moll K, Jonsson C, Normark J, Ribacke U, EgwangTG, Ekre HP, Spillmann D, Chen Q, Wahlgren M, 2006. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog 2: e100.
21. Kyriacou HM, Steen KE, Raza A, Arman M, Warimwe G, Bull PC, Havlik I, Rowe JA, 2007. In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate. Antimicrob Agents Chemother 51: 1321-1326.
22. Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Sangare L, Coulibaly S, Dakouo B, Taylor TE, Doumbo OK, Plowe CV, 2003. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg 69: 253-259.
23. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-lbeta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637.
24. Deans AM, Lyke KE, Thera MA, Plowe CV, Kone A, Doumbo OK, Kai O, Marsh K, Mackinnon MJ, Raza A, Rowe JA, 2006. Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am J Trop Med Hyg 74: 554-563.
25. Lyke KE, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Traore K, Plowe CV, Doumbo OK, 2004. Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine 22: 3169-3174.
26. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA, 2005. Community permission for medical research in developing countries. Clin Infect Dis 41: 255-259.
27. WHO, 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1):S1-S90.
28. Marsh K, Forster D, Waruiru C,Mwangi I, Winstanley M,Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R, 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
29. Arman M, Raza A, Tempest LJ, Lyke KE, Thera MA, Kone A, Plowe CV, Doumbo OK, Rowe JA, 2007. Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children. Am J Trop Med Hyg 77: 943-946.
30. Crawley MJ, 2002. Statistical Computing: An Introduction to Data Analysis using S-Plus. Chichester: John Wiley & Sons.
31. Venables WN, Ripley BD, 2002. Modern Applied Statistics with S. New York: Springer.
32. Rogerson SJ.Tembenu R, Dobano C, Plitt S,Taylor TE,Molyneux ME, 1999. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg 61: 467-472.
33. Marsh K, Snow RW, 1997. Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc Lond B Biol Sci 352: 1385-1394.
34. Nash GB, Cooke BM, Carlson J, Wahlgren M, 1992. Rheological properties of rosettes formed by red blood cells parasitized by Plasmodium falciparum. Br J Haematol 82: 757-763.
35. Chotivanich KT, Dondorp AM, White NJ, Peters K, Vreeken J, Kager PA, Udomsangpetch R, 2000. The resistance to physiological shear stresses of the erythrocytic rosettes formed by cells infected with Plasmodium falciparum. Ann Trop Med Parasitol 94: 219-226.
36. Fry AE, Griffiths MJ, Auburn S, Diakite M, Forton JT, Green A, Richardson A, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP, 2008. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 17: 567-576.
37. Jallow M.Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, Sanjoaquin M, Achidi EA,AgbenyegaT,Allen A,Amodu O.Corran P.Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe CV, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S,Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP, 2009. Genome-Wide and Fine-Resolution Association Analysis of Malaria in West Africa. Nature Genetics 41: 657-665.
38. Carlson J, Wahlgren M, 1992. Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. J Exp Med 176: 1311-1317.
39. Udomsangpetch R, Todd J, Carlson J, Greenwood BM, 1993. The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg 48: 149-153.
40. Chen Q, Heddini A, Barragan A, FernandezV, Pearce SF,Wahlgren M, 2000. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med 192: 1-10.
41. Skorokhod A, Schwarzer E, Gremo G, Arese P, 2007. HNE produced by the malaria parasite Plasmodium falciparum generates HNE-protein adducts and decreases erythrocyte deformability. Redox Rep 12: 73-75.
42. Barragan A, Spillmann D, Kremsner PG, Wahlgren M, Carlson J, 1999. Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol 91: 133-143.
43. Kaneko Y, Yoshida O, Nakagawa R,YoshidaT, Date M,Ogihara S, Shioya S, Matsuzawa Y, Nagashima N, Irie Y, et al., 1990. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro. Biochem Pharmacol 39: 793-797.
44. Havlik I, Looareesuwan S, Vannaphan S, Wilairatana P, Krudsood S.Thuma PE, Kozbor D, Watanabe N, Kaneko Y, 2005. Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 99: 333-340.